B. Metzler seel. Sohn & Co. AG Sells 1,776 Shares of Intuitive Surgical, Inc. $ISRG

B. Metzler seel. Sohn & Co. AG lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,701 shares of the medical equipment provider’s stock after selling 1,776 shares during the quarter. B. Metzler seel. Sohn & Co. AG’s holdings in Intuitive Surgical were worth $10,591,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in ISRG. Newbridge Financial Services Group Inc. boosted its holdings in Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares in the last quarter. Holos Integrated Wealth LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $25,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth about $27,000. Finally, Caitlin John LLC bought a new position in Intuitive Surgical in the 3rd quarter worth about $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price on the stock in a research note on Wednesday, March 11th. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. Finally, Leerink Partners decreased their price objective on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a report on Wednesday. Eighteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $586.70.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $483.62 on Thursday. Intuitive Surgical, Inc. has a one year low of $427.84 and a one year high of $603.88. The stock has a 50-day moving average of $477.54 and a 200 day moving average of $515.41. The company has a market capitalization of $171.75 billion, a price-to-earnings ratio of 58.62, a PEG ratio of 3.52 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.96%. The business’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.81 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 8.16 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 220 shares of Intuitive Surgical stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 32,943 shares of company stock valued at $17,279,568. Insiders own 0.60% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat on top and bottom lines — Intuitive reported $2.50 non‑GAAP EPS vs. ~$2.08 expected and $2.77B revenue (≈23% YoY), which drove the immediate market rally. ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
• Positive Sentiment: Procedure growth is the operational driver — combined da Vinci and Ion procedures grew meaningfully (da Vinci ≈16% and Ion ≈39% in Q1), supporting recurring consumables and service revenue. Intuitive Announces First Quarter Earnings
• Positive Sentiment: Company raised full‑year/procedure guidance — management modestly lifted its procedure-growth outlook for 2026, which investors read as validation that demand is holding. Intuitive Surgical Jumps 7% on Earnings Beat and Raised Full-Year Outlook
• Neutral Sentiment: Analyst reactions are mixed but active — several firms raised targets or reiterated Buys (Goldman, Baird), while others trimmed targets; net impact is more analyst attention and updated model assumptions. Analysts Boost Forecasts After Upbeat Q1
• Neutral Sentiment: Market volatility around the print — shares initially moved in after‑hours trading and then again on the next session as investors parsed the beat vs. the tone of guidance. Reuters: Intuitive Beats Quarterly Expectations
• Negative Sentiment: Guidance viewed as conservative by some — a few investors and writers note the raise was smaller than the quarter’s beat, and management flagged international headwinds; that tempers expectations for sustained upside. Why Robotics Giant Intuitive Surgical Dropped Despite Its Beat And Raise

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.